Home » Topics » BioWorld Science

BioWorld Science
RSS

Safety and efficacy of anti-PD-1 antibody SHR-1210 plus apatinib in refractory HCC, GC and EGJC

June 27, 2018

Enteris reports results from final arm of phase IIa trial of Ovarest

June 27, 2018

Increasing the sensitivity of mu-opioid receptors

June 27, 2018

Stemline Therapeutics completes rolling BLA submission to the FDA for Elzonris

June 27, 2018

Phase II results for CLT-008 in patients receiving AML induction therapy

June 27, 2018

First-in-human data reported for AMV-564 in patients with relapsed/refractory AML

June 27, 2018

Safety and immunogenicity of ZMapp antibody cocktail for Ebola virus tested in healthy adults

June 27, 2018

Navitor Pharmaceuticals initiates phase I trial of NV-5138 for treatment-resistant depression

June 27, 2018

AD and ID

June 27, 2018

CHMP adopts positive trend vote recommending the approval of the MAA for neratinib

June 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...